Latest period
$704.85M
YoY change
+158.9%
5Y CAGR
+21.8%
Peak year (2025)
$738.98M
Latest annual
$738.98M
Total Equity history chart for Insmed (INSM) from 1999 to 2025
Latest: $738.98M
Total Equity growth chart for Insmed (INSM) from 1999 to 2025
Latest: +158.9%
Total Equity history table for Insmed (INSM) from 1999 to 2025
| 2025 | $738.98M | +158.9% | +$453.60M | ||
| 2024 | $285.38M | -186.0% | +$617.30M | ||
| 2023 | −$331.92M | -477.4% | −$419.87M | ||
| 2022 | $87.95M | -78.6% | −$322.52M | ||
| 2021 | $410.47M | +48.8% | +$134.58M | ||
| 2020 | $275.88M | +5.4% | +$14.21M | ||
| 2019 | $261.67M | +25.6% | +$53.41M | ||
| 2018 | $208.27M | -42.3% | −$152.79M | ||
| 2017 | $361.06M | +133.7% | +$206.58M | ||
| 2016 | $154.48M | -50.4% | −$157.22M | ||
| 2015 | $311.70M | +67.4% | +$125.46M | ||
| 2014 | $186.24M | +29.9% | +$42.91M | ||
| 2013 | $143.32M | +18.6% | +$22.44M | ||
| 2012 | $120.88M | -10.0% | −$13.38M | ||
| 2011 | $134.27M | -30.4% | −$58.58M | ||
| 2010 | $192.84M | +55.6% | +$68.93M | ||
| 2009 | $123.91M | -4489.4% | +$126.74M | ||
| 2008 | −$2.82M | -124.6% | −$14.31M | ||
| 2007 | $11.49M | -17.2% | −$2.39M | ||
| 2006 | $13.88M | +31.8% | +$3.35M | ||
| 2005 | $10.53M | +45.5% | +$3.29M | ||
| 2004 | $7.24M | -72.4% | −$18.98M | ||
| 2003 | $26.22M | +11.8% | +$2.77M | ||
| 2002 | $23.45M | -60.7% | −$36.25M | ||
| 2001 | $59.70M | -38.3% | −$37.09M | ||
| 2000 | $96.78M | +2069.2% | +$92.32M | ||
| 1999 | $4.46M | — | — |
- 2025$738.98M+158.9%
- 2024$285.38M-186.0%
- 2023−$331.92M-477.4%
- 2022$87.95M-78.6%
- 2021$410.47M+48.8%
- 2020$275.88M+5.4%
- 2019$261.67M+25.6%
- 2018$208.27M-42.3%
- 2017$361.06M+133.7%
- 2016$154.48M-50.4%
- 2015$311.70M+67.4%
- 2014$186.24M+29.9%
- 2013$143.32M+18.6%
- 2012$120.88M-10.0%
- 2011$134.27M-30.4%
- 2010$192.84M+55.6%
- 2009$123.91M-4489.4%
- 2008−$2.82M-124.6%
- 2007$11.49M-17.2%
- 2006$13.88M+31.8%
- 2005$10.53M+45.5%
- 2004$7.24M-72.4%
- 2003$26.22M+11.8%
- 2002$23.45M-60.7%
- 2001$59.70M-38.3%
- 2000$96.78M+2069.2%
- 1999$4.46M—
Total Equity values are taken from Insmed's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Insmed (INSM)
According to Insmed's latest reported financial statements, the company's latest reported total equity is $704.85M. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total equity for Insmed (INSM) came in at $738.98M – surged 158.9% year-over-year.
Insmed total equity compound annual growth for the 2020–2025 (5 years) window is +21.8%, sustaining 2 straight years of year-over-year growth.
The record annual total equity stands at $738.98M, reached in 2025; the historical low of −$331.92M was recorded in 2023.
Insmed Total Equity by Year
Insmed Total Equity 2025: $738.98M
In 2025, Insmed reported total equity of $738.98M, surged 158.9% from 2024. This figure represents the highest annual value in the available history.
Insmed Total Equity 2024: $285.38M
Insmed total equity in 2024 was $285.38M, plunged 186.0% below 2023.
Insmed Total Equity 2023: −$331.92M
2023's total equity for Insmed came in at −$331.92M, plunged 477.4% below 2022. This figure represents the lowest annual value in the available history.
Insmed Total Equity 2022: $87.95M
Insmed posted total equity of $87.95M in 2022, plunged 78.6% below 2021.
Insmed Total Equity 2021: $410.47M
Insmed total equity in 2021 was $410.47M.
See more financial history for Insmed (INSM).
Sector peers by Total Equity
Healthcare peers of Insmed (INSM), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation